Innkeepr
Innkeepr is an audience optimization platform designed to enhance digital marketing effectiveness by leveraging causal AI to identify and target profitable lookalike and retargeting audiences. The platform aims to optimize ad spend by 20% and is tailored for direct-to-consumer companies, integrating seamlessly with major advertising platforms like Meta, Google, TikTok, and Klaviyo. With a focus on improving return on ad spend (ROAS), Innkeepr offers flexible pricing and personalized support to help businesses reach new customers efficiently.
Visit WebsiteChemnitz, Germany
Similar Startups
aimpower
AIMpower is a startup focused on enhancing marketing effectiveness through AI-driven creative testing informed by neuroscience. Their platform, brainsuite, provides detailed analyses and recommendations on consumer engagement with creative assets, helping brands quantify attention, emotional engagement, and branding impact while significantly reducing research costs.
StrategyBridgeAI
StrategyBridgeAI focuses on providing automated, data-driven business and industry analyses tailored for private equity, corporate strategy, M&A advisors, and consultants. By leveraging extensive financial competition data and industry expertise, their AI generates objective insights that simplify complex decision-making processes, enhancing efficiency and ensuring comprehensive data capture for informed strategies.
NASH RENEWABLES
NASH Renewables is a startup focused on renewable energy solutions, although specific offerings and details about their services are not provided on the website. They appear to emphasize innovation in the renewable sector, potentially through their NASH|dev initiative, but further information is needed to clarify their exact focus and product offerings.
Virtonomy
Virtonomy focuses on accelerating and de-risking medical device development through its innovative v-Patients platform, which utilizes digital patient twins for virtual testing and simulation. By leveraging a comprehensive database of clinical data, the platform enables developers to optimize device design, reduce costs, and enhance the likelihood of clinical trial success, all while complying with regulatory standards.